fda statement on compounded semaglutide Some people are overdosing semaglutide, warns | What you should know Compounded GLP-1s: Why doctors worry

van Gestel RA et al

DPP-4 Inhibitors: Renoprotective Potential and Pharmacokinetics in Type 2 Diabetes Mellitus Patients with Renal Impairment

BPC, chemically, looks like a smaller part of that natural protein

Physicians soon noticed that patients using these medications experienced significant weight loss as a side effect, prompting researchers to investigate their potential for obesity treatment

In parallel, advanced drug delivery, such as nanotechnology-based drug delivery platforms aim to improve targeting, efficacy, and patient compliance while minimizing side effects [94,95,96]

This is due to the dose escalation or titration schedule, where the medication is started at a low dose (e.g., 0.25 mg weekly) and gradually increased every four weeks, if tolerated, until the maintenance dose is achieved